Lomvastomig
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lomvastomig, covering 2025-08-20 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus [Phase 2]